HCMT
PDLI

Highland Capital Management (Tennessee)’s PDL BioPharma, Inc. PDLI Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-708
Closed -$5K – 722
2015
Q2 		$5K Buy
+708
New +$4.74K ﹤0.01% 590

Other funds holding PDLI

ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Highland Capital Management (Tennessee)'s PDLI Position: Q3 2015 in Review

Highland Capital Management (Tennessee) sold out of PDL BioPharma, Inc. (PDLI) in Q3 2015, closing a stake of 708 shares — an estimated $5K sold.

Highland Capital Management (Tennessee) first reported a position in PDLI in Q2 2015 and held it in 1 quarter. The position peaked at $5K in Q2 2015. 213 funds tracked by Wall St. Rank hold PDLI as of Q3 2015.

  • Highland Capital Management (Tennessee) reported no remaining PDL BioPharma, Inc. position as of Q3 2015 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 708 PDL BioPharma, Inc. shares in Q3 2015, an estimated $5K.
  • Highland Capital Management (Tennessee) first reported a position in PDL BioPharma, Inc. in Q2 2015 and held it in 1 quarter.
  • Highland Capital Management (Tennessee)'s PDL BioPharma, Inc. position peaked at $5K in Q2 2015.
  • 213 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2015.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q3 2015, filed 12 Nov 2015.